All News

Pharmacists can also ensure proper education and selection of therapy before and after discharge.

By offering personalized guidance, promoting awareness, and fostering open communication, pharmacists can empower their patients to navigate the new year with a focus on both wellness and safety.

Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA, discusses the multifaceted role of oncology pharmacists in diverse care settings, emphasizing their collaboration in treatment decisions and adaption in the evolving landscape of cancer care.

The combination resulted in numerically longer OS compared with an NSAI alone.

Pharmacy owner submitted fake claims stating that patients used coupons

Jennifer Marsh, PharmD, BCCCP, discusses the current standard of care for hepatic encephalopathy, highlighting challenges in treatment, prescription drug coverage, transition of care, and outpatient treatment access.

The approval marks dupilumab as the first and only FDA-approved medicine to treat pediatric patients with eosinophilic esophagitis.

The candidate has already demonstrated anti-tumor activity in chemotherapy-naïve patients.

Creating additional space for nursing mothers can be challenging in small pharmacies

Since 2000, as the number of CDIs has surged, morbidity and mortality also have increased.

Treating older patients requires a greater focus on treating their AD without exacerbating their comorbidities.

Gabriella Farkas, MD PhD, addresses the multifaceted role of pharmacists in the mental health and wellness space

A risk-stratification screening approach that considers screening at an earlier age based on risk factors might increase the likelihood of catching the cancer before it turns symptomatic.

The MRD-guided treatment approach has a significant advantage over chemotherapy.

Migraine headaches are considered a leading cause of disability around the world.

Tune in to this special episode for an exclusive insight into the future of health technology and wearable innovation, including a glimpse into the world of CES 2024.

According to the FDA review, patients with CKD receiving denosumab for osteoporosis who are on dialysis or have CKD-MBD are at the highest risk of severe hypocalcemia.

Tune into this episode as Dae Lee, PharmD, Esq, CPBS , and Harini Bupathi, Esq, attorneys at Frier Levitt, engage in a thought-provoking conversation on the evolving landscape of pharmacy benefit manager (PBM) audit strategies, regulations, and enforcement.

SAB is a complicated disease state with a high mortality rate.

Compared with chemotherapy, nivolumab plus ipilimumab reduced the risk of disease progression or death by 79%, but further research is needed to assess overall survival.

Migraines are not a one-size-fits-all condition, and there is no one-size-fits-all solution.

A recent study sheds light on an alarming number of hormone-disrupting chemicals that are found in everyday settings.

It can also help identify patients who would benefit from disease-specific therapies.

New sentences that had different linguistic properties than traditional sentences drove brain activity, according to the study authors.

There may be a pathophysiological basis for therapy relating to the to the gut-liver axis.